31. Maintenance therapy for advanced non-small-cell lung cancer: ready for clinical practice?. Issue 4 (April 2012) Authors: Sibille, Anne; Wauters, Isabelle; Vansteenkiste, Johan Journal: Expert review of anticancer therapy Issue: Volume 12:Issue 4(2012) Page Start: 529 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
32. Melanoma-associated antigen-A3 vaccination in the treatment of non-small-cell lung cancer. (March 2014) Authors: Adam, Valerie; Wauters, Isabelle; Vansteenkiste, Johan Journal: Expert opinion on biological therapy Issue: Volume 14:Number 3(2014:Mar.) Page Start: 365 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
33. Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer. Issue 6 (20th February 2023) Authors: Fukuoka, Masahiro; Yano, Seiji; Giaccone, Giuseppe; Tamura, Tomohide; Nakagawa, Kazuhiko; Douillard, Jean-Yves; Nishiwaki, Yutaka; Vansteenkiste, Johan; Kudoh, Shinzoh; Rischin, Danny; Eek, Richard; Horai, Takeshi; Noda, Kazumasa; Takata, Ichiro; Smit, Egbert; Averbuch, Steven; Macleod, Angela; F... Journal: Journal of clinical oncology Issue: Volume 41:Issue 6(2023) Page Start: 1162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
34. Outcome after PORT in ypN2 or R1/R2 versus no PORT in ypN0 Stage III‐N2 NSCLC after Induction Chemotherapy and Resection. Issue 11 (November 2016) Authors: Billiet, Charlotte; Peeters, Stéphanie; Decaluwé, Herbert; Vansteenkiste, Johan; Dooms, Christophe; Deroose, Christophe M.; Hendrikx, Marc; De Leyn, Paul; Bulens, Paul; Karim, Rezaul; Le Péchoux, Cécile; Mebis, Jeroen; De Ruysscher, Dirk Journal: Journal of thoracic oncology Issue: Volume 11:Issue 11(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
35. Patterns of Locoregional Relapses in Patients with Contemporarily Staged Stage III‐N2 NSCLC Treated with Induction Chemotherapy and Resection: Implications for Postoperative Radiotherapy Target Volumes. Issue 9 (September 2016) Authors: Billiet, Charlotte; De Ruysscher, Dirk; Peeters, Stéphanie; Decaluwé, Herbert; Vansteenkiste, Johan; Dooms, Christophe; Deroose, Christophe M.; De Leyn, Paul; Hendrikx, Marc; Bulens, Paul; Le Péchoux, Cécile; Mebis, Jeroen Journal: Journal of thoracic oncology Issue: Volume 11:Issue 9(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
36. Perspectives of Novel Imaging Techniques for Staging, Therapy Response Assessment, and Monitoring of Surveillance in Lung Cancer. Issue 2 (February 2015) Authors: Henzler, Thomas; Goldstraw, Peter; Wenz, Frederik; Pirker, Robert; Weder, Walter; Apfaltrer, Paul; Meyer, Mathias; Buesing, Karen; Crino, Lucio; Fennell, Dean; Fink, Christian; Grunenwald, Dominique; Manegold, Christian; Pilz, Lothar; Schoenberg, Stefan O.; Suresh, Senan; Vansteenkiste, Johan; Vo... Journal: Journal of thoracic oncology Issue: Volume 10:Issue 2(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
37. Perspectives of Novel Imaging Techniques for Staging, Therapy Response Assessment, and Monitoring of Surveillance in Lung Cancer: Summary of the Dresden 2013 Post WCLC-IASLC State-of-the-Art Imaging Workshop. Issue 2 (February 2015) Authors: Henzler, Thomas; Goldstraw, Peter; Wenz, Frederik; Pirker, Robert; Weder, Walter; Apfaltrer, Paul; Meyer, Mathias; Buesing, Karen; Crino, Lucio; Fennell, Dean; Fink, Christian; Grunenwald, Dominique; Manegold, Christian; Pilz, Lothar; Schoenberg, Stefan O.; Suresh, Senan; Vansteenkiste, Johan; Vo... Journal: Journal of thoracic oncology Issue: Volume 10:Issue 2(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
38. Phase II study of afatinib, an irreversible ErbB family blocker, in demographically and genotypically defined lung adenocarcinoma. Issue 1 (April 2015) Authors: De Grève, Jacques; Moran, Teresa; Graas, Marie-Pascale; Galdermans, Daniella; Vuylsteke, Peter; Canon, Jean-Luc; Schallier, Denis; Decoster, Lore; Teugels, Erik; Massey, Dan; Chand, Vikram K.; Vansteenkiste, Johan Journal: Lung cancer Issue: Volume 88:Issue 1(2015:Apr.) Page Start: 63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
39. Phase II study of afatinib, an irreversible ErbB family blocker, in demographically and genotypically defined lung adenocarcinoma. Issue 1 (April 2015) Authors: De Grève, Jacques; Moran, Teresa; Graas, Marie-Pascale; Galdermans, Daniella; Vuylsteke, Peter; Canon, Jean-Luc; Schallier, Denis; Decoster, Lore; Teugels, Erik; Massey, Dan; Chand, Vikram K.; Vansteenkiste, Johan Journal: Lung cancer Issue: Volume 88:Issue 1(2015:Apr.) Page Start: 63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
40. Phase III, randomized, open-label study of durvalumab (MEDI4736) in combination with tremelimumab or durvalumab alone versus platinum-based chemotherapy in first-line treatment of patients with advanced/metastatic NSCLC: MYSTIC. Issue 2 (December 2015) Authors: Rizvi, Naiyer; Barlesi, Fabrice; Brahmer, Julie; Felip, Enriqueta; Forde, Patrick; Garassino, Marina; Goldberg, Sarah; Vansteenkiste, Johan; Jarkowski, Anthony; McIntosh, Stuart; Zhao, Luping; Antonia, Scott Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗